Blend Labs, Inc. (BLND)
NYSE: BLND · Real-Time Price · USD
5.18
+0.11 (2.07%)
Nov 21, 2024, 12:04 PM EST - Market open
Blend Labs Income Statement
Financials in millions USD. Fiscal year is January - December.
Millions USD. Fiscal year is Jan - Dec.
Fiscal Year | TTM | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 |
---|---|---|---|---|---|---|
Period Ending | Sep '24 Sep 30, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 | Dec '19 Dec 31, 2019 |
Revenue | 156.72 | 156.85 | 235.2 | 234.5 | 96.03 | 50.67 |
Revenue Growth (YoY) | -4.17% | -33.31% | 0.30% | 144.19% | 89.51% | - |
Cost of Revenue | 71.17 | 75.71 | 145.55 | 118.51 | 34.29 | 19.55 |
Gross Profit | 85.54 | 81.14 | 89.65 | 115.99 | 61.74 | 31.12 |
Selling, General & Admin | 95.55 | 130.82 | 224.37 | 212.88 | 81.53 | 64.25 |
Research & Development | 51.64 | 81.59 | 138.09 | 92.22 | 55.5 | 48.6 |
Operating Expenses | 147.19 | 212.41 | 370.87 | 313.23 | 137.03 | 112.85 |
Operating Income | -61.65 | -131.27 | -281.22 | -197.24 | -75.29 | -81.72 |
Interest Expense | -13.83 | -30.81 | -24.79 | -11.28 | - | - |
Interest & Investment Income | 6.8 | 11.4 | 2.4 | 0.4 | 1 | - |
Currency Exchange Gain (Loss) | - | - | -0.5 | - | - | - |
Other Non Operating Income (Expenses) | -3.9 | -4.16 | 0.13 | 0.09 | -0.3 | 0.28 |
EBT Excluding Unusual Items | -72.59 | -154.84 | -303.98 | -208.03 | -74.59 | -81.44 |
Merger & Restructuring Charges | -8.05 | -24.95 | -15.28 | - | - | - |
Impairment of Goodwill | - | - | -287.23 | - | - | - |
Gain (Loss) on Sale of Investments | 4.42 | - | 2.88 | - | - | - |
Asset Writedown | - | - | -162.45 | - | - | - |
Other Unusual Items | -5.47 | 0 | - | - | - | - |
Pretax Income | -73.08 | -179.79 | -766.05 | -208.03 | -74.59 | -81.44 |
Income Tax Expense | 0.01 | 0.09 | -2.24 | -38.89 | 0.03 | 0.01 |
Earnings From Continuing Operations | -73.09 | -179.88 | -763.81 | -169.14 | -74.62 | -81.45 |
Minority Interest in Earnings | 0.28 | 1.19 | 43.64 | -0.77 | - | - |
Net Income | -72.81 | -178.69 | -720.17 | -169.91 | -74.62 | -81.45 |
Preferred Dividends & Other Adjustments | 12.98 | 6.63 | 48.44 | 1.43 | - | - |
Net Income to Common | -85.79 | -185.32 | -768.61 | -171.34 | -74.62 | -81.45 |
Shares Outstanding (Basic) | 252 | 245 | 234 | 132 | 39 | 33 |
Shares Outstanding (Diluted) | 252 | 245 | 234 | 132 | 39 | 33 |
Shares Change (YoY) | 3.80% | 4.72% | 77.41% | 234.93% | 20.23% | - |
EPS (Basic) | -0.34 | -0.76 | -3.28 | -1.30 | -1.89 | -2.49 |
EPS (Diluted) | -0.34 | -0.76 | -3.28 | -1.30 | -1.89 | -2.49 |
Free Cash Flow | -36.49 | -128.21 | -192.49 | -129.39 | -66.34 | -59.52 |
Free Cash Flow Per Share | -0.14 | -0.52 | -0.82 | -0.98 | -1.68 | -1.82 |
Gross Margin | 54.58% | 51.73% | 38.12% | 49.46% | 64.29% | 61.42% |
Operating Margin | -39.34% | -83.70% | -119.57% | -84.11% | -78.40% | -161.28% |
Profit Margin | -54.74% | -118.15% | -326.79% | -73.07% | -77.70% | -160.75% |
Free Cash Flow Margin | -23.29% | -81.74% | -81.84% | -55.18% | -69.08% | -117.46% |
EBITDA | -59.24 | -128.81 | -270.46 | -186.64 | -71.3 | -80.76 |
EBITDA Margin | -37.80% | -82.13% | -114.99% | -79.59% | -74.25% | -159.38% |
D&A For EBITDA | 2.41 | 2.46 | 10.77 | 10.61 | 3.99 | 0.96 |
EBIT | -61.65 | -131.27 | -281.22 | -197.24 | -75.29 | -81.72 |
EBIT Margin | -39.34% | -83.70% | -119.57% | -84.11% | -78.40% | -161.28% |
Revenue as Reported | 156.72 | 156.85 | 235.2 | 234.5 | - | - |
Advertising Expenses | - | - | - | - | 3.6 | 4.1 |
Source: S&P Capital IQ. Standard template. Financial Sources.